Skip to content
PubMed This is a summary of 52 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 52 referenced papers

Top Authors

Robert Alexander Hegele
Western University
Željko Reiner
University Hospital Centre Zagreb
Robert S. Rosenson
Mount Sinai Hospital
Winfried März
Medical University of Graz
Barak Zafrir
Technion – Israel Institute of Technology
Savitha Subramanian
University of Washington
James J. Maciejko
Wayne State University
Chen Shapira
Technion – Israel Institute of Technology
Ayman Jubran
Carmel Medical Center
Rawan Hijazi
Technion – Israel Institute of Technology

Top Institutions

Ranked by publications Top 10 institutions
05

Icahn School of Medicine at Mount Sinai

New York, United States

17 papers
06

Manchester University NHS Foundation Trust

Manchester, United Kingdom

17 papers
08

University Hospital Leipzig

Leipzig, Germany

14 papers
10

Cook Children's Medical Center

Fort Worth, United States

9 papers

References

References (52)
  1. 1

    Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

    Yang P, Subbaiah PV

    Biochimica et biophysica acta 2015; (1851(10)):1327-36.

    PMID: 26193433
  2. 2

    Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.

    Kobayashi J, Miyashita K, Nakajima K, Mabuchi H

    Journal of atherosclerosis and thrombosis 2015; (22(10)):1001-11 doi:10.5551/jat.31617.

    PMID: 26194979
  3. 3

    Clinical Study of 224 Patients with Hypertriglyceridemia Pancreatitis.

    Zhang XL, Li F, Zhen YM, et al.

    Chinese medical journal 2015; (128(15)):2045-9 doi:10.4103/0366-6999.161361.

    PMID: 26228216
  4. 4

    [Severe hypertriglyceridemia induced acute pancreatitis: a case report and review of the literature].

    Herrera Del Águila DD, Garavito Rentería J, Linarez Medina K, Lizarzaburu Rodríguez V

    Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 2015; (35(2)):159-64.

    PMID: 26228982
  5. 5

    Primary hypertriglyceridemia in children and adolescents.

    Shah AS, Wilson DP

    Journal of clinical lipidology 2015; (9(5 Suppl)):S20-8.

    PMID: 26343209
  6. 6

    Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.

    Andrés-Blasco I, Herrero-Cervera A, Vinué Á, et al.

    The Journal of endocrinology 2015; (227(3)):179-91 doi:10.1530/JOE-15-0219.

    PMID: 26423094
  7. 7

    Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood.

    Langslet G, Bogsrud MP, Halvorsen I, et al.

    Journal of clinical lipidology 2015; (9(6)):778-785 doi:10.1016/j.jacl.2015.08.008.

    PMID: 26687698
  8. 8

    A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.

    Liu Y, Lun Y, Lv W, et al.

    Journal of clinical lipidology 2016; (10(1)):199-203.e1.

    PMID: 26892137
  9. 9

    Hypertriglyceridemic pancreatitis associated with confounding laboratory abnormalities.

    Melnick S, Nazir S, Gish D, Aryal MR

    Journal of community hospital internal medicine perspectives 2016; (6(3)):31808 doi:10.3402/jchimp.v6.31808.

    PMID: 27406459
  10. 10

    High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

    Tani M, Horvath KV, Lamarche B, et al.

    Atherosclerosis 2016; (253()):7-14 doi:10.1016/j.atherosclerosis.2016.08.014.

    PMID: 27573733
  11. 11

    Insulin Clearance Is Associated with Hepatic Lipase Activity and Lipid and Adiposity Traits in Mexican Americans.

    Labadzhyan A, Cui J, Péterfy M, et al.

    PloS one 2016; (11(11)):e0166263 doi:10.1371/journal.pone.0166263.

    PMID: 27846285
  12. 12

    Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.

    Maciejko JJ

    American journal of cardiovascular drugs : drugs, devices, and other interventions 2017; (17(3)):217-231 doi:10.1007/s40256-017-0216-5.

    PMID: 28197978
  13. 13

    Lysosomal acid lipase deficiency in all siblings of the same parents.

    Maciejko JJ, Anne P, Raza S, Lyons HJ

    Journal of clinical lipidology 2017; (11(2)):567-574 doi:10.1016/j.jacl.2017.02.006.

    PMID: 28502515
  14. 14

    Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.

    Buonuomo PS, Rabacchi C, Macchiaiolo M, et al.

    Journal of clinical lipidology 2017; (11(6)):1329-1337.e3 doi:10.1016/j.jacl.2017.08.017.

    PMID: 28951076
  15. 15

    Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.

    Murase T, Okubo M, Ebara T, Mori Y

    Journal of clinical lipidology 2017; (11(6)):1383-1392 doi:10.1016/j.jacl.2017.08.006.

    PMID: 28958672
  16. 16

    PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes.

    Hess CN, Low Wang CC, Hiatt WR

    Annual review of medicine 2018; (69()):133-145 doi:10.1146/annurev-med-042716-091351.

    PMID: 29095667
  17. 17

    2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.

    Goldberg IJ

    Arteriosclerosis, thrombosis, and vascular biology 2018; (38(4)):700-706 doi:10.1161/ATVBAHA.117.309666.

    PMID: 29419410
  18. 18

    Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service.

    Zafrir B, Jubran A, Hijazi R, Shapira C

    Journal of clinical lipidology 2018; (12(4)):928-936 doi:10.1016/j.jacl.2018.03.086.

    PMID: 29685592
  19. 19

    Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.

    Williams L, Rhodes KS, Karmally W, et al.

    Journal of clinical lipidology 2018; (12(4)):908-919 doi:10.1016/j.jacl.2018.04.010.

    PMID: 29804909
  20. 20

    Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.

    Chaudhry R, Viljoen A, Wierzbicki AS

    Expert review of clinical pharmacology 2018; (11(6)):589-598 doi:10.1080/17512433.2018.1480368.

    PMID: 29842811
  21. 21

    Diagnostic Algorithm for Cholesteryl Ester Storage Disease: Clinical Presentation in 19 Polish Patients.

    Lipiński P, Ługowska A, Zakharova EY, et al.

    Journal of pediatric gastroenterology and nutrition 2018; (67(4)):452-457 doi:10.1097/MPG.0000000000002084.

    PMID: 29958253
  22. 22

    Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.

    Falko JM

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018; (24(8)):756-763 doi:10.4158/EP-2018-0157.

    PMID: 30183397
  23. 23

    Abruptio Placentae Caused by Hypertriglyceridemia-Induced Acute Pancreatitis during Pregnancy: Case Report and Literature Review.

    Yalcin Bahat P, Turan G, Aslan Cetin B

    Case reports in obstetrics and gynecology 2018; (2018()):3869695 doi:10.1155/2018/3869695.

    PMID: 30254776
  24. 24

    Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy.

    Reiner Ž

    Korean circulation journal 2018; (48(12)):1097-1119 doi:10.4070/kcj.2018.0343.

    PMID: 30403015
  25. 25

    Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease.

    Wang Y, Shen L, Xu D

    Clinical cardiology 2019; (42(1)):56-61 doi:10.1002/clc.23104.

    PMID: 30511426
  26. 26

    Severe Hypertriglyceridemia-Related Pancreatitis: Characteristics and Predictors of Recurrence.

    Zafrir B, Saliba W, Jubran A, et al.

    Pancreas 2019; (48(2)):182-186 doi:10.1097/MPA.0000000000001235.

    PMID: 30629026
  27. 27

    LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.

    Silbernagel G, Scharnagl H, Kleber ME, et al.

    Atherosclerosis 2019; (282()):37-44 doi:10.1016/j.atherosclerosis.2018.12.024.

    PMID: 30685440
  28. 28

    Pleiotropic association of LIPC variants with lipid and urinary 8-hydroxy deoxyguanosine levels in a Taiwanese population.

    Teng MS, Wu S, Hsu LA, et al.

    Lipids in health and disease 2019; (18(1)):111 doi:10.1186/s12944-019-1057-9.

    PMID: 31077211
  29. 29

    Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy.

    Cohen JL, Burfield J, Valdez-Gonzalez K, et al.

    Orphanet journal of rare diseases 2019; (14(1)):198 doi:10.1186/s13023-019-1129-y.

    PMID: 31412917
  30. 30

    The Diagnosis and Treatment of Hypertriglyceridemia.

    Parhofer KG, Laufs U

    Deutsches Arzteblatt international 2019; (116(49)):825-832.

    PMID: 31888796
  31. 31

    Lipase C, Hepatic Type -250A/G (rs2070895) Variant Enhances Carotid Atherosclerosis in Normolipidemic and Asymptomatic Individuals from Brazil.

    Zago VHS, Parra ES, Virgínio VWM, et al.

    Lipids 2020; (55(3)):225-237 doi:10.1002/lipd.12232.

    PMID: 32196671
  32. 32

    Can genetic testing help in the management of dyslipidaemias?

    Lazarte J, Hegele RA

    Current opinion in lipidology 2020; (31(4)):187-193 doi:10.1097/MOL.0000000000000690.

    PMID: 32520779
  33. 33

    Management of Hypertriglyceridemia: Common Questions and Answers.

    Oh RC, Trivette ET, Westerfield KL

    American family physician 2020; (102(6)):347-354.

    PMID: 32931217
  34. 34

    Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases.

    Giammanco A, Noto D, Barbagallo CM, et al.

    Life (Basel, Switzerland) 2021; (11(6)) doi:10.3390/life11060581.

    PMID: 34207236
  35. 35

    A Modern Approach to Dyslipidemia.

    Berberich AJ, Hegele RA

    Endocrine reviews 2022; (43(4)):611-653 doi:10.1210/endrev/bnab037.

    PMID: 34676866
  36. 36

    Approach to the Patient With Moderate Hypertriglyceridemia.

    Subramanian S

    The Journal of clinical endocrinology and metabolism 2022; (107(6)):1686-1697 doi:10.1210/clinem/dgac085.

    PMID: 35184196
  37. 37

    Hypertriglyceridemia Induced Acute Pancreatitis Caused by a Novel LIPC Gene Variant in a Pediatric Patient.

    Balanescu L, Cardoneanu A, Stanciu G, et al.

    Children (Basel, Switzerland) 2022; (9(2)) doi:10.3390/children9020188.

    PMID: 35204909
  38. 38

    The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence.

    Luna-Castillo KP, Olivares-Ochoa XC, Hernández-Ruiz RG, et al.

    Nutrients 2022; (14(5)) doi:10.3390/nu14051104.

    PMID: 35268076
  39. 39

    Hypertriglyceridemia-Induced Pancreatitis and a Lipemic Blood Sample: A Case Report and Brief Clinical Review.

    Ahern BJ, Yi HJ, Somma CL

    Journal of emergency nursing 2022; (48(4)):455-459 doi:10.1016/j.jen.2022.02.001.

    PMID: 35337668
  40. 40

    A case of eruptive xanthomas associated with pregnancy unmasking a G188E heterozygous mutation of the lipoprotein lipase gene: A case report.

    Paquette C, Careau AM, Bergeron J, et al.

    SAGE open medical case reports 2022; (10()):2050313X221131865 doi:10.1177/2050313X221131865.

    PMID: 36274861
  41. 41

    Acute pancreatitis secondary to moderate hypertriglyceridemia: A case report.

    Nepali A, Kharga S, Jayan M, et al.

    Clinical case reports 2024; (12(3)):e8582 doi:10.1002/ccr3.8582.

    PMID: 38464586
  42. 42

    Severe Hypertriglyceridemia in Patients with Type 2 Diabetes Mellitus Participating in the AMD Annals Initiative.

    Russo GT, Manicardi V, Rocca A, et al.

    Metabolic syndrome and related disorders 2024; (22(9)):661-668 doi:10.1089/met.2024.0093.

    PMID: 39088376
  43. 43

    Phenotype in Individuals with Heterozygous Rare Variants in LIPC Encoding Hepatic Lipase.

    Jacob EO, Wang J, McIntyre AD, Hegele RA

    International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111445.

    PMID: 39518997
  44. 44

    Identification of a Pathogenic Mutation of the Lipase Maturation Factor 1 (LMF1) Gene Causing Recurrent Pancreatitis and Requiring Critical Care.

    Montalvo AF, González-Andrade F, Molestina MJ, et al.

    Journal of clinical medicine 2025; (14(6)) doi:10.3390/jcm14061827.

    PMID: 40142634
  45. 45

    Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism.

    Dijk W, Rimbert A, Sotin T, et al.

    Arteriosclerosis, thrombosis, and vascular biology 2026; (46(1)):105-118 doi:10.1161/ATVBAHA.125.323051.

    PMID: 41230597
  46. 46

    Dysbetalipoproteinaemia in genetically predisposed Ghanaians.

    Ateko RO, Marais AD, Blom DJ, et al.

    Lipids in health and disease 2025; (24(1)):367 doi:10.1186/s12944-025-02787-0.

    PMID: 41250040
  47. 47

    Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review.

    Subramanian S, Soran H, Sikora Kessler A, et al.

    European journal of internal medicine 2025; 106648 doi:10.1016/j.ejim.2025.106648.

    PMID: 41444050
  48. 48

    Post-heparin plasma lipase activities in patients with severe hypertriglyceridemia treated with evinacumab.

    Vitali C, Banerjee P, Pordy R, et al.

    Journal of lipid research 2026; (67(4)):101020 doi:10.1016/j.jlr.2026.101020.

    PMID: 41831525
  49. 49

    Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

    Bork C, Nordestgaard BG, Hedegaard BS, et al.

    Atherosclerosis 2026; (418()):120757 doi:10.1016/j.atherosclerosis.2026.120757.

    PMID: 42178198
  50. 50

    Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia.

    Ferrandino M, Cerrato Y, Iannuzzo G, et al.

    Genes 2026; (17(6)) doi:10.3390/genes17060721.

    PMID: 42353880
  51. 51

    Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia.

    Kassem BA, Shaik FA, Sorour O, et al.

    Journal of cardiovascular pharmacology 2026; (88(2)):123-131 doi:10.1097/FJC.0000000000001846.

    PMID: 42359618
  52. 52

    Management of complex lipid disorders in a community lipid clinic setting: Implementing a multidisciplinary model.

    Miyamoto MI, Ko C, Chiu ST, et al.

    Journal of clinical lipidology 2026; doi:10.1016/j.jacl.2026.08.022.

    PMID: 42754460